Skip to main content
Thomas Samuelson, MD, Ophthalmology, Minnetonka, MN

Thomas W Samuelson MD

Glaucoma Related


Founding Partner and Attending Surgeon of Minnesota Eye Consultants, P.A.

Join to view full profile
  • 10709 Wayzata BlvdSte 200Minnetonka, MN 55305

  • Phone+1 952-888-5800

  • Fax+1 952-567-6156

Dr. Samuelson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
    Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Glaucoma, 1991
  • University of South Florida Morsani
    University of South Florida MorsaniResidency, Ophthalmology, 1990
  • Marshfield Clinic
    Marshfield ClinicInternship, Transitional Year, 1985 - 1986
  • University of Minnesota
    University of MinnesotaM.D., Medicine, 1981 - 1985
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1985

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1986 - 2027
  • FL State Medical License
    FL State Medical License 1987 - 1998
  • PA State Medical License
    PA State Medical License 1990 - 1991
  • WI State Medical License
    WI State Medical License 1986 - 1987
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2014-2017
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2014-2017
  • America's Top Doctors Castle Connolly, 2002-2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma
    ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle GlaucomaDecember 3rd, 2025
  • ViaLase Treats First Patient in US IDE Clinical Trial for Incision-Free, Femtosecond Laser Glaucoma Procedure
    ViaLase Treats First Patient in US IDE Clinical Trial for Incision-Free, Femtosecond Laser Glaucoma ProcedureMarch 12th, 2025
  • Vialase Announces Positive Results of First-in-Human Study of Femtosecond Laser Image-Guided High Precision Trabeculotomy
    Vialase Announces Positive Results of First-in-Human Study of Femtosecond Laser Image-Guided High Precision TrabeculotomyFebruary 3rd, 2023

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: